AIM IMMUNOTECH INC. Accounts Receivable, Related Parties, Current
AIM IMMUNOTECH INC. (AIM) had Accounts Receivable, Related Parties, Current of $1.68 million as of 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Notes
us-gaap:AccountsReceivableRelatedPartiesCurrent · last filed 2023-03-31
- 2022-12-31: Accounts Receivable, Related Parties, Current $1.68M.
- 2022-03-31: Accounts Receivable, Related Parties, Current $1.64M.
- 2021-12-31: Accounts Receivable, Related Parties, Current $1.64M.
- 2021-03-31: Accounts Receivable, Related Parties, Current $1.09M.
| Period end | Accounts Receivable, Related Parties, Current |
|---|---|
| 2022-12-31 | $1.68M 10-K · filed 2023-03-31 |
| 2022-03-31 | $1.64M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $1.64M 10-K · filed 2023-03-31 |
| 2021-03-31 | $1.09M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $1.09M 10-K · filed 2022-03-31 |
| 2020-03-31 | $776.00K 10-Q · filed 2020-05-14 |
| 2019-12-31 | $776.00K 10-K · filed 2021-03-31 |
| 2018-12-31 | $859.00K 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |